The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Anticipations for ELCC 2023
Milica Kontic Jovanovic, MD, PhD, Clinical Center of Serbia, Belgrade, Serbia, discusses what she is excited to hear more about at European Lung Cancer Congress (ELCC) 2023, including conversations surrounding targeted therapy and immunotherapy for the treatment of early stage lung cancer. Dr Jovanovic also looks forward to the presentations focusing on selecting patients that are suitable candidates for these treatment approaches. This interview took place at ELCC 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws
